Alerts will be sent to your verified email
Verify Email
LAURUSLABS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Laurus Labs Limited offers a wide range of Active Pharma Ingredients (API), Generic Finished dosage forms (FDF), and Contract Research services globally, focusing on areas like anti-retroviral, Hepatitis C, and Oncology drugs through continuous innovation.
Laurus Labs major competitors are Neuland Laboratories, Granules India, Alivus Life Sciences, Acutaas Chemicals, Shilpa Medicare, Aarti Pharmalabs, Supriya Lifescience.
Market Cap of Laurus Labs is ₹46,436 Crs.
While the median market cap of its peers are ₹11,571 Crs.
Laurus Labs seems to be less financially stable compared to its competitors.
Altman Z score of Laurus Labs is 7.27 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||||||||
| Investor Presentation | Apr Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Apr Jun Jul Sep Dec | Jan Mar Jun Sep Dec | Mar Jun Sep Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
